Sarah A. Salmon

In Vitro Activity of Ceftiofur and its Primary Metabolite, Desfuroylceftiofur, against Organisms of Veterinary Importance

Ceftiofur (XNL) and its primary metabolite, desfuroylceftiofur (DXNL), were evaluated for in vitro activity against 539 isolates from veterinary sources. Actinobacillus pleuropneumoniae, Pasteurella spp., Haemophilus somnus, Salmonella spp., Escherichia coli, staphylococci, and streptococci were tested. Overall, XNL and DXNL were equivalent in activity against the gram-negative organisms with all minimum inhibitory concentrations (MICs) within 1 serial dilution. Against the staphylococci, MIC differences of 2–3 serial dilutions were detected with an MIC90 for XNL and DXNL of 1.0 and 4.0–8.0 g/ml, respectively. Although the MIC90 obtained for Streptococcus suis for each compound was within 1 dilution, the MIC values against individual strains were 2–3 dilutions greater for DXNL than for XNL. The MICs obtained with the bovine and equine streptococci for DXNL (MIC90 = 0.03 g/ml) were 5 serial dilutions higher than those obtained for XNL (MIC90 £ 0.0019). Although DXNL was less active than XNL against the streptococci, these differences were not clinically important because both XNL and DXNL were highly active for these bacteria. Although these differences are of little importance with the streptococci, they may have important implications for susceptibility testing of the staphylococci. In conclusion, with the exception of the staphylococci, both XNL and DXNL were highly active against the organisms tested, with MICs for both compounds several fold lower than plasma levels achieved during dosing of XNL.

Minimum Inhibitory Concentration Determinations for Various Antimicrobial Agents against 1570 Bacterial Isolates from Turkey Poults

Minimum inhibitory concentrations (MICs) were determined for 1570 bacteria from eight geographic locations (1204 Escherichia coli, 231 other enteric gram-negative bacilli [including Citrobacter spp., Enterobacter spp., Klebsiella spp., Proteus spp., and Salmonella spp.], 31 Pseudomonas spp., 18 coagulase-positive staphylococci, 26 coagulase-negative staphylococci, and 55 streptococci and enterococci) by the National Committee for Clinical Laboratory Standards broth microdilution procedure. Antimicrobial agents tested included ampicillin, ceftiofur, enrofloxacin, erythromycin, florfenicol, gentamicin, neomycin, spectinomycin, sulfamethazine, tetracycline, and trimethoprim/sulfadiazine. Against the E. coli strains tested, ceftiofur, enrofloxacin, gentamicin, and trimethoprim/sulfadiazine were the most active compounds with MIC at which 50% of the strains are at or below (MIC50) = 0.5, < or = 0.03, 0.5, and 0.13 microg/ml, respectively, and MIC at which 90% of the strains are at or below (MIC90) = 1.0, 0.13, 32.0, and 2.0 microg/ml, respectively. Ampicillin, florfenicol, neomycin, and spectinomycin were the next most active compounds against the E. coli strains, with MIC50 = 4.0, 4.0, 16.0, and 16.0 microg/ml, respectively. MIC90 values for these compounds against E. coli strains were > 32.0, 8.0, 512.0, and > 128.0 microg/ml, respectively. The remaining compounds exhibited limited, strain-dependent activity against the E. coli strains tested. As with the E. coli, enrofloxacin, ceftiofur, and trimethoprim/sulfadiazine were also the most active compounds against the 231 other enteric organisms tested, with MIC50 < or = 1.0 microg/ml for all of these genera. The remaining compounds exhibited limited activity against these genera. Against the gram-positive cocci tested, ampicillin, enrofloxacin, ceftiofur, and trimethoprim/sulfadiazine were most active, whereas the remaining compounds exhibited strain-dependent activity. When MIC data for E. coli were summarized separately, differences were observed between the geographic locations for the various antimicrobial agents. In conclusion, ceftiofur, enrofloxacin, and trimethoprim/sulfadiazine were the most active of the compounds tested against all of the bacterial strains.

MICs of Oxazolidinones for Rhodococcus equi Strains Isolated from Humans and Animals

ABSTRACT Eperezolid and linezolid are representatives of a new class of orally active, synthetic antimicrobial agents. The in vitro activity values (MICs) of linezolid, eperezolid, and comparator antibiotics against 102 strains of Rhodococcus equi isolated from humans and animals were determined. Linezolid was more active than eperezolid against the strains tested; premafloxacin was the most active comparator antibiotic.

Minimum Inhibitory Concentrations of Bacteria Isolated from Septicemia and Airsacculitis in Ducks

epidemic of necrotic enteritis with symptoms identical to those described here. However, recent changes in management, including stress reduction, the addition of roughage to the diet, exposure to adult gastrointestinal microflora, and the replacement of the sulfamerazine with oral penicillin, have reduced the mortality by approximately 50%. Permanent institution of these measures (prior to clinical signs) could prevent or greatly reduce mortality in future outbreaks. Clostridium difficile enterotoxemia may be a common problem in captive ostrich chicks, and the utilization of early diagnosis by selective culture, biochemical identification, and ELISA enterotoxin assay may limit the potential for severe mortality. Acknowledgement. This work was partially supported by NIH grant 1P40RR04326-01. 10.

Minimum inhibitory concentrations of selected antimicrobial agents against bacteria isolated from 1-14-day-old broiler chicks.

5. DaMassa AJ, Brooks DL, Adler HE, Watt DE: 1983, Caprine 9. Gardella RS, DelGiudice RA, Tully JG: 1983, Immunofluomycoplasmosis: acute pulmonary disease in newborn kids given rescence. Methods Mycoplasmal 1:431-439. Mycoplasma capricolum orally. Aust Vet J 60: 125-126. 10. Rosendal S: 1981, Experimental infection of goats, sheep, and 6. DaMassa AJ, Brooks DL, Holmberg CA, Moe AI: 1987, Capcalves with the large colony type of Mycoplasma mycoides subsp. rine mycoplasmosis: an outbreak of mastitis and arthritis remycoides. Vet Pathol 18:71-81. quiring the destruction of 700 goats. Vet Rec 120:409-413. 11. Smith MC, Sherman DM: 1994, Reproductive system. In: Goat 7. DaMassa AJ, Wakenell PS, Brooks DL: 1992, Mycoplasmas medicine, pp. 411-463. Lea and Febiger, Philadelphia, PA. of goats and sheep. J Vet Diagn Invest 4:101-113. 8. Freundt EA: 1983, Culture media for classic mycoplasmas. Methods Mycoplasmal 1:127-135.

Evaluation of a Commercial System for the Identification of Gram-Negative, Nonfermenting Bacteria of Veterinary Importance

8. Ferris KE, Miller DA: 1990, Salmonella serotypes from animals and related sources reported during July 1989-June 1990. Proc Annu Meet US Anim Health Assoc 94:463-478. 9. Ferris KE, Miller DA: 1991, Salmonella serotypes from animals and related sources reported during July 1990-June 1991. Proc Annu Meet US Anim Health Assoc 95:440-454. 10. Ferris KE, Miller DA: 1992, Salmonella serotypes from animals and related sources reported during July 1991-June 1992. Proc Annu Meet US Anim Health Assoc 96:492-504. 11. Gibbons DF: 1980, Equine salmonellosis: a review. Vet Rec 106:356-359. 12. Hird DW, Casebolt DB, Carter JD, et al.: 1986, Risk factors for salmonellosis in hospitalized horses. J Am Vet Med Assoc 188:173-177. 13. Hird DW, Pappaioanou M, Smith BP: 1984, Case control study of risk factors associated with isolation of Salmonella saint paul in hospitalized horses. Am J Epidemiol 120:852-864. 14. Hook EW: 1990, Salmonella species (including typhoid fever). In: Principles and practice of infectious diseases, ed. Mandell GL, Douglas RG, Bennett JE, 3rd ed., pp. 1700-1716. Churchill Livingston, New York, NY. 15. Ikeda JS, Hirsh DC: 1985, Common plasmid encoding resistance to ampicillin, chloramphenicol, gentamicin, and trimethoprim-sulfadiazine in two serotypes of Salmonella isolated during an outbreak of equine salmonellosis. Am J Vet Res 46:769773. 16. Ikeda JS, Hirsh DC, Jang SS, Biberstein EL: 1986, Characteristics of Salmonella isolated from animals at a veterinary medical teaching hospital. Am J Vet Res 47:232-235. 17. Lund LJ, Atkinson WI, Holt GJ: 1991, Transmission of Salmonella to veterinarians. Vet Rec 129:415. 18. Mathewson JJ, Simpson RB, Roush DA: 1981, Isolation of antibiotic-resistant Salmonella krefeld from clinical veterinary materials. Antimicrob Agents Chemother 19:355-356. 19. Morse EV, Duncan MA, Fessler JF, Page EH: 1976, The treatment of salmonellosis in Equidae. Mod Vet Pract 57:47-51. 20. Morse EV, Duncan MA, Page EA, Fessler JF: 1976, Salmonellosis in Equidae: a study of 23 cases. Cornell Vet 66:198213. 21. National Committee for Clinical Laboratory Standards: 1990, Approved standard M2-A4. Performance standards for antimicrobial disk susceptibility tests. National Committee for Clinical Laboratory Standards, Villanova, PA. 22. National Committee for Clinical Laboratory Standards: 1990, Approved standard M7-A2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, PA. 23. National Committee for Clinical Laboratory Standards: 1992, Fourth information supplement M100-S4. Performance standards for antimicrobial susceptibility testing. National Committee for Clinical Laboratory Standards, Villanova, PA. 24. Owen RR, Fullerton J, Barnum DA: 1983, Effects of transportation, surgery, and antibiotic therapy in ponies infected with Salmonella. Am J Vet Res 44:46-50. 25. Palmer JE, Benson CE: 1984, Salmonella shedding in the equine. Proc Int Symp Salmonella, pp. 161-164. 26. Smith BP: 1981, Equine salmonellosis: a contemporary view. Equine Vet J 13:147-151.

Isolation of Gardnerella Vaginalis from the Reproductive Tract of Four Mares

A gram-variable pleomorphic bacillus was isolated from the reproductive tracts of 4 mares during routine prebreeding soundness examinations. Using a commercial bacterial identification system, these organisms were identified as Streptococcus acidominimus. However, colonial and Gram-staining characteristics did not support this identification. Subsequent testing indicated the organism was similar to Gardnerella vaginalis. Additional growth and biochemical analysis performed in our laboratory and at the Michigan Department of Public Health and by the Center for Disease Control, Atlanta, Georgia, confirmed the identification of G. vaginalis.